Supernus Pharmaceuticals (SUPN) EBT Margin (2011 - 2026)
Supernus Pharmaceuticals (SUPN) reported EBT Margin of -26.32% for Q2 2026, down 36.39 percentage points from 10.07% a year earlier.
Powered by 
Analysis
Supernus Pharmaceuticals (SUPN) EBT Margin (2011 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Supernus Pharmaceuticals' EBT Margin came in at -12.79%, down 25.15 percentage points year-over-year; for FY2025, it came in at -6.82%, down 21.61 percentage points from FY2024.
- EBT Margin has a five-year change of -39.23 percentage points (FY2020 to FY2025).
- By year, EBT Margin came in at 14.79% in FY2024 (+14.33 pp), 0.46% in FY2023 (-8.65 pp), 9.10% in FY2022 (-3.52 pp) and 12.62% in FY2021 (-19.79 pp).
- Five-year quarterly EBT Margin spans a low of -30.17% in Q3 2025 and a high of 25.58% in Q3 2024.
- Year over year, EBT Margin gained in two of the last seven quarters, with an average year-over-year change of -12.01 percentage points.
- The high point for year-over-year EBT Margin in five years was Q2 2024 (a gain of 28.26 percentage points); the low point was Q3 2025 (a drop of 55.75 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 26.66% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 25.18% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | -4.11% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 29.63% |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 18.19% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 27.53% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -131.41% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -4.34% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 41.75% |
| 10 | Supernus Pharmaceuticals | 2.56 Bn | 1.21 Bn | 185.39 Mn | -26.32% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -26.32% |
| Dec 31, 2025 | -0.90% |
| Sep 30, 2025 | -30.17% |
| Jun 30, 2025 | 10.07% |
| Mar 31, 2025 | -3.89% |
| Dec 31, 2024 | 15.15% |
| Sep 30, 2024 | 25.58% |
| Jun 30, 2024 | 15.63% |
| Mar 31, 2024 | 0.17% |
| Dec 31, 2023 | 0.60% |
| Sep 30, 2023 | 6.43% |
| Jun 30, 2023 | -12.63% |
| Mar 31, 2023 | 5.86% |
| Dec 31, 2022 | 21.00% |
| Sep 30, 2022 | -0.25% |
| Jun 30, 2022 | 6.66% |
| Mar 31, 2022 | 9.65% |
| Dec 31, 2021 | 1.29% |
| Sep 30, 2021 | 19.51% |
| Jun 30, 2021 | 22.10% |
API Access
Supernus Pharmaceuticals EBT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebt-margin&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebt-margin", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebt-margin&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();